Search results for " Connective tissue disease"

showing 10 items of 848 documents

ISOLATION PROCEDURE, SPECIES IDENTIFICATION AND CLINICAL SIGNIFICANCE OF ASPERGILLUS SPP., SCEDOSPORIUM SPP., AND OTHER FILAMENTOUS FUNGI IN CYSTIC F…

2008

Pulmonary and Respiratory MedicineAspergillusbiologybusiness.industrymedicine.diseaseIsolation (microbiology)biology.organism_classificationCystic fibrosisMicrobiologyScedosporiumPediatrics Perinatology and Child HealthmedicineSpecies identificationClinical significancePediatrics Perinatology and Child Healthbusinessskin and connective tissue diseasesJournal of Cystic Fibrosis
researchProduct

Pulmonary aspergilloma in a patient with AIDS.

1995

Aspergillus infections are rare in the course of AIDS. They mostly occur as invasive destructive disease in patients with severe CD4 cell depletion. An unusual case of a homosexual AIDS patient who developed a pulmonary aspergilloma is presented.

Pulmonary and Respiratory MedicineMalemedicine.medical_specialtyPathologyAIDS-Related Opportunistic InfectionsAspergillosisAcquired immunodeficiency syndrome (AIDS)Amphotericin BmedicineAspergillosisHumansskin and connective tissue diseasesMycosisLungAIDS-Related Opportunistic InfectionsLung Diseases Fungalbusiness.industryAspergillus fumigatusRespiratory diseaseMiddle Agedmedicine.diseaseDermatologymedicine.anatomical_structureItraconazoleComplicationbusinessAspergillomaResearch Article
researchProduct

Urticaria and bacterial infections

2014

The association between urticaria and infectious diseases has been discussed for >100 years. However, a causal relationship with underlying or precipitating infection is difficult to establish. The purpose of this work was to perform a systematic analysis of the published cases of urticaria associated with bacterial infections. We give an umbrella breakdown of up-to-date systematic reviews and other important publications on the complex association of urticaria and bacterial infections. We did a Medline search, for English language articles published until January 2014, using the key words "urticaria" and "bacteria/bacterial disease"; a second analysis was performed in groups of bacteria an…

Pulmonary and Respiratory MedicineUrticariaPATHOGENESISCHILDRENBrucellaLyme diseaseANGIOEDEMAimmune system diseasesHELICOBACTER-PYLORIMYCOPLASMA-PNEUMONIAE INFECTION; HELICOBACTER-PYLORI; LYME-DISEASE; ANGIOEDEMA; CHILDREN; BRUCELLOSIS; VASCULITIS; MANIFESTATIONS; PATHOGENESIS; EOSINOPHILIAparasitic diseasesHumansImmunology and AllergyMedicineVASCULITISskin and connective tissue diseasesBRUCELLOSISBacterial diseaseChlamydiaEOSINOPHILIAAngioedemabiologybusiness.industryLYME-DISEASEBacterial InfectionsGeneral MedicineHelicobacter pylorimedicine.diseasebiology.organism_classificationMANIFESTATIONSMycoplasma pneumoniaImmunologyMYCOPLASMA-PNEUMONIAE INFECTIONmedicine.symptombusinessPneumonia (non-human)
researchProduct

EVIDENCE BASED MEDICINE - ONE AID IN PROVIDING GOOD CF CARE

2008

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryFamily medicinePediatrics Perinatology and Child HealthAlternative medicinemedicinePediatrics Perinatology and Child HealthEvidence-based medicineskin and connective tissue diseasesbusinessJournal of Cystic Fibrosis
researchProduct

A PATIENT-ORIENTED LABORATORY MODEL FOR CYSTIC FIBROSIS (CF)

2008

Pulmonary and Respiratory Medicinemedicine.medical_specialtybusiness.industryPediatrics Perinatology and Child HealthPatient orientedMedicinePediatrics Perinatology and Child HealthRadiologybusinessmedicine.diseaseskin and connective tissue diseasesCystic fibrosisJournal of Cystic Fibrosis
researchProduct

Severe asthma and COVID-19: lessons from the first wave

2020

Objective: Severe asthma is considered a risk factor for SARS-Coronavirus 2 (SARS-CoV-2) infection but scientific evidences are lacking. Methods: we performed a literature search and review based on PubMed database national, international recommendations as well as papers on severe asthmatic patients and their management during SARS-CoV-2 pandemic. Results: the majority of international recommendations, expert panels and editorials provide indications about management of severe asthmatic patients. No published studies evaluated the effects of biologic agents on severe asthmatic patients during SARS-CoV-2 pandemic. Conclusions: the relationship between SARS-CoV-2 and asthma is variable world…

Pulmonary and Respiratory Medicinesevere asthma2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)biologic agentsvirusesSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Severe asthmaInhaled corticosteroidsSettore MED/10 - Malattie Dell'Apparato Respiratoriooral corticosteroids03 medical and health sciences0302 clinical medicineRisk FactorsInternal medicinemedicineHumansImmunology and AllergyAnti-Asthmatic AgentsPediatrics Perinatology and Child Health030212 general & internal medicineRisk factorskin and connective tissue diseasesPandemicsAsthmabusiness.industryAsthma; biologic agents; COVID-19; inhaled corticosteroids; oral corticosteroids; SARS-CoV-2; severe asthmaSARS-CoV-2fungiPatient AcuityAsthma biologic agents COVID-19 inhaled corticosteroids oral corticosteroids SARS-CoV-2 severe asthmaCOVID-19medicine.diseaseAsthmarespiratory tract diseasesBiologic Agentsbody regions030228 respiratory systemPractice Guidelines as TopicPediatrics Perinatology and Child Healthinhaled corticosteroidsbusiness
researchProduct

Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position…

2011

To cite this article: Baiardini I, Braido F, Bindslev-Jensen C, Bousquet PJ, Brzoza Z, Canonica GW, Compalati E, Fiocchi A, Fokkens W, Gerth van Wijk R, Giménez-Arnau A, Godse K, Grattan C, Grob JJ, La Grutta S, Kalogeromitros D, Kocatürk E, Lombardi C, Mota-Pinto A, Ridolo E, Saini SS, Sanchez-Borges M, Senna GE, Terreehorst I, Todo Bom A, Toubi E, Bousquet J, Zuberbier T, Maurer M. Recommendations for assessing patient-reported outcomes and health-related quality of life in patients with urticaria: a GA(2) LEN taskforce position paper. Allergy 2011; 66: 840-844. ABSTRACT: The aim of this Global Allergy and Asthma European Network (GA(2) LEN) consensus report is to provide recommendations …

QuestionnairesClinical Trials as TopicUrticariaQuestionnaireGa2LenhumanitiesOutcome Assessment (Health Care)Treatment Outcomeimmune system diseasesSurveys and QuestionnairesOutcome Assessment Health Careparasitic diseasesChronic DiseaseQuality of LifeHumansQuestionnaires; Humans; Treatment Outcome; Clinical Trials as Topic; Quality of Life; Urticaria; Outcome Assessment (Health Care); Chronic DiseaseUrticáriaskin and connective tissue diseasesHumanQualidade de Vida
researchProduct

Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins

2021

Antiphospholipid antibodies (aPL), assumed to cause antiphospholipid syndrome (APS), are notorious for their heterogeneity in targeting phospholipids and phospholipid-binding proteins. The persistent presence of Lupus anticoagulant and/or aPL against cardiolipin and/or β2-glycoprotein I have been shown to be independent risk factors for vascular thrombosis and pregnancy morbidity in APS. aPL production is thought to be triggered by–among other factors–viral infections, though infection-associated aPL have mostly been considered non-pathogenic. Recently, the potential pathogenicity of infection-associated aPL has gained momentum since an increasing number of patients infected with Severe Acu…

RNA virusesPulmonologyCoronavirusesPhysiology2405 ParasitologyAntibody Response030204 cardiovascular system & hematologyBiochemistrychemistry.chemical_compoundMedical Conditions0302 clinical medicineimmune system diseasesImmune PhysiologyMedicine and Health SciencesCardiolipinMedicineBiology (General)skin and connective tissue diseasesImmune ResponsePathology and laboratory medicineCOVIDVirus Testing0303 health sciencesLupus anticoagulantImmune System Proteinsbiologymedicine.diagnostic_test2404 MicrobiologyProteasesMedical microbiologyEnzymes3. Good healthInfectious DiseasesCoagulationVirusesSARS CoV 2PathogensAntibodyResearch ArticleSARS coronavirusQH301-705.5Immunology10208 Institute of Neuropathology610 Medicine & healthSARS-CoV-2; Respiratory infections; Virus testing; serine proteases; Antibody response; Autoantibodies; Blood plasma; ImmunoassaysResearch and Analysis MethodsMicrobiologyAntibodiesRespiratory Disorders03 medical and health sciences1311 GeneticsDiagnostic MedicineAntiphospholipid syndromeVirology1312 Molecular BiologyGeneticsImmunoassaysneoplasmsMolecular BiologyAutoantibodies030304 developmental biology030203 arthritis & rheumatology2403 ImmunologyPregnancyBiology and life sciencesbusiness.industryOrganismsViral pathogensAutoantibodyProteinsRC581-607medicine.diseaseMicrobial pathogenschemistry19ImmunoassayRespiratory InfectionsImmunology2406 VirologyEnzymologyImmunologic Techniquesbiology.protein570 Life sciences; biologyParasitologyImmunologic diseases. AllergySerine ProteasesbusinessPLOS Pathogens
researchProduct

Targeted Therapy Modulates the Secretome of Cancer-Associated Fibroblasts to Induce Resistance in HER2-Positive Breast Cancer

2021

The combination of trastuzumab plus pertuzumab plus docetaxel as a first-line therapy in patients with HER2-positive metastatic breast cancer has provided significant clinical benefits compared to trastuzumab plus docetaxel alone. However, despite the therapeutic success of existing therapies targeting HER2, tumours invariably relapse. Therefore, there is an urgent need to improve our understanding of the mechanisms governing resistance, so that specific therapeutic strategies can be developed to provide improved efficacy. It is well known that the tumour microenvironment (TME) has a significant impact on cancer behaviour. Cancer-associated fibroblasts (CAFs) are essential components of the…

Receptor ErbB-2Cancer-associated fibroblastQH301-705.5breast cancer; HER2-positive; tumour microenvironment; targeted therapy; trastuzumab; resistance; cancer-associated fibroblast; label-free proteomics; miRNABreast NeoplasmsDocetaxelAntibodies Monoclonal HumanizedArticleCatalysisInorganic ChemistryresistanceDrug Delivery SystemsLabel-free proteomicsbreast cancerCancer-Associated FibroblastsCell Line TumorAntineoplastic Combined Chemotherapy ProtocolsHumansPhysical and Theoretical ChemistryBiology (General)skin and connective tissue diseasesMolecular BiologyQD1-999SpectroscopymiRNAOrganic ChemistryGeneral Medicinetargeted therapyHER2-positiveComputer Science ApplicationstrastuzumabChemistryDrug Resistance NeoplasmFemaletumour microenvironmentInternational Journal of Molecular Sciences
researchProduct

Erbb2 regulates neuromuscular synapse formation and is essential for muscle spindle development

2003

Neuregulins and their Erbb receptors have been implicated in neuromuscular synapse formation by regulating gene expression in subsynaptic nuclei. To analyze the function of Erbb2 in this process, we have inactivated the Erbb2 gene in developing muscle fibers by Cre/Lox-mediated gene ablation. Neuromuscular synapses form in the mutant mice, but the synapses are less efficient and contain reduced levels of acetylcholine receptors. Surprisingly, the mutant mice also show proprioceptive defects caused by abnormal muscle spindle development. Sensory Ia afferent neurons establish initial contact with Erbb2-deficient myotubes. However, functional spindles never develop. Taken together, our data su…

Receptor ErbB-2Muscle spindleNeuromuscular JunctionMice TransgenicBiologySynaptic TransmissionNeuromuscular junctionSynapseMiceErbB ReceptorsmedicineAnimalsHumansMuscle SkeletalPromoter Regions Geneticskin and connective tissue diseasesMuscle SpindlesMolecular BiologyAcetylcholine receptorMice KnockoutAfferent PathwaysMyogenesisGenes erbB-2ActinsMice Mutant StrainsCell biologyMice Inbred C57BLmedicine.anatomical_structureSilent synapseNeuregulinSignal TransductionDevelopmental BiologyDevelopment
researchProduct